Loading stock…

Quaker Chemical Corporation (KWR) Stock Verdict & Ratings | Investment Bastion

Stock Verdict·Updated 1d ago

Quaker Chemical Corporation

KWRMarket cap $2.71BPrice $157.3

Country🇺🇸United States

SectorMaterials

IndustryChemicals

Makes industrial process fluids that keep metal from grinding, tearing, or melting during manufacturing—used everywhere from steel mills to car plants. It's the world's largest pure-play industrial lubricant maker, quietly greasing the machinery behind nearly every metal product you touch.

In Bastion Portfolios?

52W Return+21%Global Market +16%?

01Key Ratings

How does this stock score across Bastion factors?

Growth

Historical Revenue

Rev CAGR (3y)-1%3

Revenue Forecast

Rev CAGR (1y)+8%5

Rev CAGR (3y)+5%4

Rev CAGR (5y)+4%4

Earnings Forecast

EPS Growth Y+10%5

EPS Growth Y+2+20%8

EPS Growth Y+3+11%7

Quality

Margins

EBIT Margin9%4

Net Income Margin5%4

Free Cash Flow Margin4%4

Debt

Net Debt/EBITDA2.53

Efficiency

ROE7%3

ROA3%5

Earnings Stability33

GEAR+VERY WEAK14

Overall rating across all five factors

Value

Price Multiples

P/E Ratio (Forward)194

P/E Ratio (Forward 3y)155

P/BV2.07

EV Multiples

EV/EBITDA Fwd116

EV/EBIT Fwd165

Yield

Free Cash Flow Yield2.8%4

Dividend Yield1.3%4

Momentum

Short term

1 month return-2%7

3 month return+7%8

YTD return+16%7

Mid term

Price vs 52wHigh87%7

1 year return+21%7

Long term

3 year return+5%3

5 year return-28%2

Risk Shield

Price Risk

Beta1.23

Volatility38%5

Free Cash Flow

Free Cash Flow Margin4%4

Free Cash Flow Yield2.8%4

Quality

ROCE8%4

Earnings Stability33

Net Debt/EBITDA2.53

02Growth

Is it actually growing, and how fast?

KWRQuaker Chemical

Revenue FY25$1.9B

GROWTH RATING↗

AVERAGE36 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-1%3

Revenue, next 1Y+8%5

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+4%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+20%8

EPS growth, FY28E+11%7

GROWTH ASSESSMENT

STRENGTHS

After shrinking over the last 3 years, revenue is set to grow 5%/yr from here.

Earnings are set to grow faster than sales (EPS about 11%/yr vs revenue 5%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 36% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Over five years revenue is set to grow 4%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

Revenue fell 1%/yr over the last 3 years, behind 70% of companies worldwide.3/10

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that's turning around. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE55 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-2%7

3-month return+7%8

YTD return+16%7

MID & LONG-TERM▾SCORE

% of 52-week high87%7

1-year return+21%7

3-year return+5%3

5-year return-28%2

MOMENTUM ASSESSMENT

STRENGTHS

It's up 21% over the past year, but 13% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (-2%), over three months (+7%) and so far this year (+16%).

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+4.7% over three years and -28% over five), behind 70% of the market.

BOTTOM LINE

Early Turnaround

A poor multi-year track record but a sharp recent rally. Momentum is turning up, yet the trend is young and unproven — it needs follow-through to confirm rather than fade. The one thing to watch: the multi-year record is weak.

04Value

Are you paying a fair price for it?

Stop guessing on Quaker Chemical Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

KWRQuaker Chemical

Revenue FY25$1.9B

GROWTH RATING↗

AVERAGE36 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR-1%3

Revenue, next 1Y+8%5

Revenue, next 3Y, CAGR+5%4

Revenue, next 5Y, CAGR+4%4

EARNINGS FORECAST▾SCORE

EPS growth, FY26E0%5

EPS growth, FY27E+20%8

EPS growth, FY28E+11%7

GROWTH ASSESSMENT

STRENGTHS

After shrinking over the last 3 years, revenue is set to grow 5%/yr from here.

Earnings are set to grow faster than sales (EPS about 11%/yr vs revenue 5%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 36% of companies worldwide.

Revenue is set to grow 5%/yr over the next 3 years, a little behind the market.4/10

Over five years revenue is set to grow 4%/yr, behind 60% of companies worldwide.4/10

WEAKNESSES

Revenue fell 1%/yr over the last 3 years, behind 70% of companies worldwide.3/10

BOTTOM LINE

Margin Expander

A middle-of-the-pack grower that's turning around. The one thing to watch: revenue has shrunk over the past 3 years.

03Price Momentum

Is the market behind it right now?

MOMENTUM RATING↗

AVERAGE55 / 100

SHORT-TERM RETURNS▾SCORE

1-month return-2%7

3-month return+7%8

YTD return+16%7

MID & LONG-TERM▾SCORE

% of 52-week high87%7

1-year return+21%7

3-year return+5%3

5-year return-28%2

MOMENTUM ASSESSMENT

STRENGTHS

It's up 21% over the past year, but 13% below its 52-week high. That is clearly ahead of the market.

Strong recent results. The stock is outperforming over the past month (-2%), over three months (+7%) and so far this year (+16%).

WATCH

None flagged.

WEAKNESSES

Weak long-term results. It has been a disappointing long-term hold (+4.7% over three years and -28% over five), behind 70% of the market.

BOTTOM LINE

Early Turnaround

04Value

Are you paying a fair price for it?

Stop guessing on Quaker Chemical Corporation. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community